Characterization of immunoliposomes for HER2-targeted delivery of the dual Rac/Cdc42 inhibitor MBQ-167

被引：0
|
作者：
Velazquez, Luis E.
Dharmawardhane, Suranganie
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1998
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1998
引用
收藏
页数：2
相关论文
共 30 条
  • [21] Characterization of the Rac/Cdc42 inhibitor MBQ-168 as an anti-cancer compound
    Medina, Julia
    Matos, Tatiana
    Velazquez, Luis
    Rivera, Michael
    Cruz-Collazo, Ailed
    Hernandez, Eliud
    Vlaar, Cornelis
    Dharmawardhane, Suranganie
    CANCER RESEARCH, 2022, 82 (04)
  • [22] Targeting Rac/Cdc42 GTPases to overcome HER2targeted therapy resistance
    Reyes, Miciely Cristal Aponte
    Vega, Luis E. Velazquez
    Dharmawardhane, Suranganie
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Validation of Cdc42 Inhibition as the Mechanism of Action of the Anti-metastatic Drug MBQ-167, Using Budding Yeast as a Model System
    Rivera-Robles, Michael John
    Medina-Velazquez, Julia
    Asencio-Torres, Gabriela
    Gonzalez-Crespo, Sahily
    Rymond, Brian C.
    Rodriguez-Medina, Jose R.
    Dharmawardhane, Suranganie
    FASEB JOURNAL, 2018, 32 (01):
  • [24] Characterization of immunoliposomes as delivery vehicles for the Rac inhibitor Ehop-016 in HER2 type breast cancer
    Rivera-Robles, Michael J.
    Vivas-Mejia, Pablo E.
    Castillo-Pichardo, Linette
    Vlaar, Cornelis
    Hernandez, Eliud
    Dharmawardhane, Suranganie
    CANCER RESEARCH, 2017, 77
  • [25] Targeting Rac/Cdc42 in human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Rivera-Robles, M. J.
    Medina-Vlazquez, J. I.
    Borrero-Garcia, L. D.
    Velazquez-Vega, L. E.
    Maldonado, Md M.
    Ruiz-Calderon, J.
    Castillo-Pichardo, L.
    Vivas-Mejia, P.
    Dharmawardhane, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [26] Identification and characterization of Asef2, a guanine–nucleotide exchange factor specific for Rac1 and Cdc42
    Y Kawasaki
    M Sagara
    Y Shibata
    M Shirouzu
    S Yokoyama
    T Akiyama
    Oncogene, 2007, 26 : 7620 - 7627
  • [27] Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42
    Kawasaki, Y.
    Sagara, M.
    Shibata, Y.
    Shirouzu, M.
    Yokoyama, S.
    Akiyama, T.
    ONCOGENE, 2007, 26 (55) : 7620 - 7627
  • [28] HER2/ErbB2-induced Breast Cancer Cell Migration and Invasion Require p120 Catenin Activation of Rac1 and Cdc42
    Johnson, Emhonta
    Seachrist, Darcie D.
    DeLeon-Rodriguez, Carlos M.
    Lozada, Kristen L.
    Miedler, John
    Abdul-Karim, Fadi W.
    Keri, Ruth A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (38) : 29491 - 29501
  • [29] Dietary limonin alleviates Salmonella Typhimurium-induced colitis via dual targeting virulence SopB and SopE2 and inhibiting RAC1/CDC42/Arp2/3 pathway and regulating gut microbiota
    Cui, Xinhua
    Wang, Yang
    Liu, Jiajia
    Liu, Ziyan
    Zhao, Meng
    Yu, Wanlu
    Zhu, Mingmei
    Xu, Hongyue
    Lu, Baochun
    Peng, Danping
    Shi, Jinyang
    Liao, Ning
    Niu, Sijia
    Shen, Jiayi
    Qiu, Jiazhang
    Yu, Lu
    FOOD & FUNCTION, 2025, 16 (03) : 1041 - 1059
  • [30] Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload
    Powell, C. A.
    Camidge, D. R.
    Gemma, A.
    Kusumoto, M.
    Baba, T.
    Kuwano, K.
    Bankier, A.
    Kiura, K.
    Tamura, K.
    Modi, S.
    Tsurutani, J.
    Doi, T.
    Iwata, H.
    Krop, I. E.
    Zhang, L.
    Jasmeet, S.
    Saito, K.
    Shahidi, J.
    Yver, A.
    Takahashi, S.
    CANCER RESEARCH, 2019, 79 (04)
123